IRON Disc Medicine Inc
Price (delayed)
$53.06
Market cap
$1.83B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.96
Enterprise value
$1.67B
Highlights
Disc Medicine's quick ratio has increased by 25% YoY and by 10% from the previous quarter
IRON's equity is up by 29% year-on-year but it is down by 5% since the previous quarter
Disc Medicine's net income has decreased by 43% YoY and by 6% QoQ
IRON's EPS is down by 16% YoY
Key stats
What are the main financial stats of IRON
Market
Valuations
Earnings
Shares outstanding
34.57M
Market cap
$1.83B
Enterprise value
$1.67B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.56
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$129.72M
Net income
-$109.36M
EBIT
-$108.43M
EBITDA
-$107.84M
Free cash flow
-$94.43M
Per share
Balance sheet
Liquidity
EPS
-$3.96
EPS diluted
-$3.96
Free cash flow per share
-$3.42
Book value per share
$14.91
Revenue per share
$0
TBVPS
$18
Total assets
$496.77M
Total liabilities
$53.19M
Debt
$30M
Equity
$443.59M
Working capital
$470.3M
Debt to equity
0.07
Current ratio
21.17
Quick ratio
21.01
Net debt/EBITDA
1.51
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-23.6%
Return on equity
-25.2%
Return on invested capital
-54.2%
Return on capital employed
-22.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRON stock price
How has the Disc Medicine stock price performed over time
Intraday
-1.61%
1 week
-4.4%
1 month
-1.92%
1 year
-18.94%
YTD
-16.31%
QTD
-16.31%
Financial performance
How have Disc Medicine's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$129.72M
Net income
-$109.36M
Gross margin
N/A
Net margin
N/A
Disc Medicine's net income has decreased by 43% YoY and by 6% QoQ
The operating income has declined by 42% year-on-year and by 3.9% since the previous quarter
Growth
What is Disc Medicine's growth rate over time
Valuation
What is Disc Medicine stock price valuation
P/E
N/A
P/B
3.56
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IRON's EPS is down by 16% YoY
IRON's equity is up by 29% year-on-year but it is down by 5% since the previous quarter
IRON's price to book (P/B) is 7% lower than its 5-year quarterly average of 3.9
Efficiency
How efficient is Disc Medicine business performance
Disc Medicine's ROIC has increased by 37% from the previous quarter
The ROE fell by 8% YoY
Disc Medicine's return on assets has decreased by 6% YoY
Dividends
What is IRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRON.
Financial health
How did Disc Medicine financials performed over time
IRON's total liabilities has surged by 133% year-on-year and by 96% since the previous quarter
The total assets is up by 35% year-on-year
The company's debt is 93% lower than its equity
IRON's equity is up by 29% year-on-year but it is down by 5% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.